White Paper
Best Practices for RWD/RWE Used in Regulatory Filings
Sep 26, 2024
Download

The contribution of real-world evidence (RWE) to regulatory submissions as supportive or substantial evidence has increased in the pre-marketing authorization space over the last decade. An extensive series of guidance documents have been put forth by the United States (US) Food and Administration (FDA) on the use of real-world data (RWD) and RWE in regulatory submissions, with several guidance themes emerging. In this white paper, we discuss key takeaways from a series of FDA guidance and review selected case studies of RWD/RWE to highlight best practices and learnings that sponsors can implement when planning and managing their regulatory submissions.

Contact Us